Medical credentials, claimed or genuine, do not make an
unverified product, a marketplace peptide, or an unsupported
benefit claim trustworthy. A clinical-looking label, a
confident explanation, or a professional title is not evidence
of identity, purity, sterility, efficacy, or safety.
Be especially cautious when someone sells or promotes products
known to have uncertain provenance, promises effects that have
no credible basis, or prepares injectable material in an
uncontrolled home environment. Reconstituting with fluid from
a non-sterile container, using unvalidated handling practices,
or allowing contamination risks around preparation is not
acceptable research or medical practice.
Ask for verifiable product identity, batch-specific testing
where relevant, sterile handling evidence, and a clear
separation between evidence, speculation, and sales claims. If
those cannot be provided, do not let status or confidence
replace basic scrutiny.
Selective harm reduction and the DIY double standard
Community leaders and moderators frequently shut down
discussions around DIY, homebrew formulations, or
self-prepared solutions under the banner of āuser safety.ā
-
The baseline reality: The entire space
revolves around unapproved, grey-market compounds without
pharmaceutical licensing. Pretending that a pre-packaged
reseller vial is inherently medical-grade while
compound-level knowledge is an unacceptable risk is a
self-serving double standard.
-
Harm reduction requires education, not
censorship:
Understanding sterile techniques, accurate unit conversions,
filtration, and storage can help people identify and reduce
risks, but it cannot establish sterility, identity, or
suitability. Gatekeeping technical knowledge keeps users
dependent and uninformed.
-
Knowledge vs. Gatekeeping: Banning
discussion on open methods, bulk sourcing, or homebrewing
can serve to protect seller markups on pre-made kits rather
than user well-being. Open-source problem solving and cost
transparency are essential to harm reduction.